Kentucky Cultivator Begins Medical Cannabis Production in Lexington

First Plants in the Ground

A Lexington-based cultivation license holder has started growing medical cannabis, making it the first active grow operation in Kentucky's regulated market. The facility received final state approval in July 2026. It's now in the vegetative phase of its first crop cycle. Kentucky's medical cannabis law, passed in March 2023 and codified as HB 136, authorized up to 40 cultivation licenses statewide.

The Department of Cannabis Control has issued 22 cultivation licenses to date. Most remain in build-out or pre-operational phases.

Timeline to Market

Kentucky's medical cannabis program is scheduled to begin retail sales on January 1, 2027, giving cultivators roughly four months to harvest, cure, test, and package inventory. Standard cannabis cultivation cycles run 90 to 120 days from clone to harvest, depending on strain and method. The Lexington facility's early start positions it to supply processors and dispensaries at launch.

The early cultivation window is tight but workable for operators who secured genetics and built infrastructure ahead of final license approval.

Kentucky law requires all medical cannabis to be tested by independent laboratories for potency, pesticides, heavy metals, and microbial contaminants before reaching patients. Four testing labs hold state licenses. All were operational as of August 2026.

Licensing Landscape

Kentucky has approved 22 cultivation licenses, 48 processor licenses, and 92 dispensary licenses across the state's 11 designated regions. Lexington sits in Region 5, which includes Fayette, Bourbon, Scott, Woodford, and Jessamine counties. Three cultivation licenses went to the region. Two are now in active build-out.

HB 136 caps the total number of cultivation licenses at 40, with a minimum of two per region. The Department of Cannabis Control hasn't announced a timeline for issuing the remaining 18 licenses. For full background on this story, see the CannIntel topic hub on Kentucky's medical cannabis program.

What Comes Next

The next operational milestone is processor activation—facilities that will convert raw flower into tinctures, capsules, and topicals for Kentucky's medical market. At least a dozen of the 48 licensed processors are expected to begin operations by October 2026, according to industry estimates. Dispensaries are completing final inspections and staff training ahead of the January launch.

Kentucky's qualifying conditions include cancer, chronic pain, epilepsy, multiple sclerosis, and post-traumatic stress disorder. The state estimates 150,000 patients will register in the program's first year.